INSERM UMR_S1109, Tumor Biomechanics, Strasbourg 67000, France; Université de Strasbourg, Strasbourg 67000, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg 67000, France.
INSERM UMR_S1109, Tumor Biomechanics, Strasbourg 67000, France; Université de Strasbourg, Strasbourg 67000, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg 67000, France.
Cell Rep. 2019 Sep 3;28(10):2491-2500.e5. doi: 10.1016/j.celrep.2019.07.102.
Cancer metastasis is a process whereby a primary tumor spreads to distant organs. We have demonstrated previously that blood flow controls the intravascular arrest of circulating tumor cells (CTCs) through stable adhesion to endothelial cells. We now aim to define the contribution of cell adhesion potential and identify adhesion receptors at play. Early arrest is mediated by the formation of weak adhesion, depending on CD44 and integrin αvβ3. Stabilization of this arrest uses integrin α5β1-dependent adhesions with higher adhesion strength, which allows CTCs to stop in vascular regions with lower shear forces. Moreover, blood flow favors luminal deposition of fibronectin on endothelial cells, an integrin α5β1 ligand. Finally, we show that only receptors involved in stable adhesion are required for subsequent extravasation and metastasis. In conclusion, we identified the molecular partners that are sequentially exploited by CTCs to arrest and extravasate in vascular regions with permissive flow regimes.
癌症转移是一种原发性肿瘤扩散到远处器官的过程。我们之前已经证明,血流通过稳定地黏附在内皮细胞上来控制循环肿瘤细胞(CTC)的血管内捕获。我们现在的目标是确定细胞黏附潜力的贡献,并确定起作用的黏附受体。早期捕获是通过形成弱黏附来介导的,这取决于 CD44 和整合素αvβ3。这种捕获的稳定化使用具有更高黏附强度的整合素α5β1 依赖性黏附,这允许 CTC 在剪切力较低的血管区域停止。此外,血流有利于纤维连接蛋白在内皮细胞上的管腔沉积,这是整合素α5β1 的配体。最后,我们表明,只有参与稳定黏附的受体才是随后的血管外渗和转移所必需的。总之,我们确定了 CTC 依次利用的分子伴侣,以在具有允许血流模式的血管区域中停止和外渗。